Similar Posts
Critics Wonder Whether the FDA Is Too Slow to Handle a Pandemic
The FDA plays a critical role in our nation’s response to the COVID-19 pandemic. It helps decide which medicines are safe and effective to treat the disease. It evaluates the accuracy and reliability of laboratory tests. And it will play a central role in assessing potential vaccines. But will the FDA bureaucracy move with the…
Medicare Drug Coverage Is Often Inadequate—Here’s Why
Your father’s rheumatoid arthritis medicine was working well, fighting off that otherwise debilitating illness. Then he found out that Medicare would no longer pay for the drug. Your aunt’s multiple sclerosis was flaring and her neurologist recommended a promising new treatment. But she learned that she would have to try, and “fail,” on two other…
Science Isn’t Meant To Be Followed
Science cannot lead us out of this pandemic. Whatever paths we take to navigate COVID-19 need to be chosen through political processes. The true role of science is to illuminate these pathways, guiding our policy choices by showing us what’s at stake.
Time To Take Tax Breaks Away From Non-Profit Hospitals
Many wealthy nonprofit hospitals provide surprisingly little charitable care.
Expert: NC better positioned than other states to respond to pandemic (WRAL)
The slow growth in coronavirus cases in North Carolina relative to New York and some other states puts North Carolina in better position to respond to the pandemic, according to a Duke University professor. Economist Mark McClellan, the director of the Duke-Margolis Center for Health Policy, was U.S. Food and Drug Administration commissioner during the…
